Relx (NYSE:RELX) Lowered to Hold Rating by StockNews.com

Relx (NYSE:RELX) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued to investors on Tuesday.

Separately, Redburn Atlantic began coverage on Relx in a research report on Wednesday, January 8th. They issued a “buy” rating for the company.

Relx Trading Up 0.3 %

NYSE:RELX opened at $48.50 on Tuesday. The stock has a fifty day moving average price of $48.42 and a two-hundred day moving average price of $47.49. The stock has a market capitalization of $90.14 billion, a price-to-earnings ratio of 26.08, a PEG ratio of 2.73 and a beta of 0.90. The company has a debt-to-equity ratio of 1.46, a quick ratio of 0.47 and a current ratio of 0.52. Relx has a 1 year low of $40.25 and a 1 year high of $51.99.

Institutional Trading of Relx

Large investors have recently bought and sold shares of the company. JPMorgan Chase & Co. grew its holdings in Relx by 14.6% in the third quarter. JPMorgan Chase & Co. now owns 826,481 shares of the technology company’s stock valued at $39,225,000 after purchasing an additional 104,999 shares during the last quarter. CWA Asset Management Group LLC acquired a new stake in Relx in the third quarter valued at $548,000. Paradigm Asset Management Co. LLC grew its holdings in Relx by 17.1% in the fourth quarter. Paradigm Asset Management Co. LLC now owns 81,600 shares of the technology company’s stock valued at $3,706,000 after purchasing an additional 11,900 shares during the last quarter. Merit Financial Group LLC acquired a new stake in Relx in the fourth quarter valued at $301,000. Finally, International Assets Investment Management LLC acquired a new stake in shares of Relx during the third quarter valued at $1,268,000. Institutional investors and hedge funds own 15.02% of the company’s stock.

About Relx

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.